5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine

C150H198F9N31O6 — CID 160789018

IUPAC5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine
SMILESCCC(C)c1nc(-c2cnc(C)c(C(F)(F)F)c2)cn1C12CC(N3CCOCC3)(C1)C2.CCC(C)c1nc(-c2cnc(N)c(C)c2)cn1C12CC(N3CCOCC3)(C1)C2.CCC(C)c1nc(-c2cnc(N)c(C)c2)cn1C12CC(N3CCOCC3)(C1)C2.CCc1nc(-c2cnc(N)c(C)c2)cn1C12CC(N3CCOCC3)(C1)C2.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC(C)C)n2)cnc1N.Cc1ncc(-c2cn(C34CC(C3)C4)c(C(C)C)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC(C)C)n2)cc1C(F)(F)F
InChIInChI=1S/2C23H29F3N4O.3C22H31N5O.C20H27N5O.C18H20F3N3/c1-15(2)8-20-28-19(17-9-18(23(24,25)26)16(3)27-10-17)11-30(20)22-12-21(13-22,14-22)29-4-6-31-7-5-29;1-4-15(2)20-28-19(17-9-18(23(24,25)26)16(3)27-10-17)11-30(20)22-12-21(13-22,14-22)29-5-7-31-8-6-29;1-15(2)8-19-25-18(17-9-16(3)20(23)24-10-17)11-27(19)22-12-21(13-22,14-22)26-4-6-28-7-5-26;2*1-4-15(2)20-25-18(17-9-16(3)19(23)24-10-17)11-27(20)22-12-21(13-22,14-22)26-5-7-28-8-6-26;1-3-17-23-16(15-8-14(2)18(21)22-9-15)10-25(17)20-11-19(12-20,13-20)24-4-6-26-7-5-24;1-10(2)16-23-15(9-24(16)17-5-12(6-17)7-17)13-4-14(18(19,20)21)11(3)22-8-13/h2*9-11,15H,4-8,12-14H2,1-3H3;3*9-11,15H,4-8,12-14H2,1-3H3,(H2,23,24);8-10H,3-7,11-13H2,1-2H3,(H2,21,22);4,8-10,12H,5-7H2,1-3H3
InChIKeySBPDEPNELOYPOK-UHFFFAOYSA-N
MW2702.43 g/mol
LogP26.07
Rot. Bonds32

About 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine

5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine (PubChem CID 160789018) has the molecular formula C150H198F9N31O6 and a molecular weight of 2702.43 g/mol. Its IUPAC name is 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine.

Molecular Properties

Compound Name5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine
PubChem CID160789018
Molecular FormulaC150H198F9N31O6
Molecular Weight2702.43 g/mol
Exact Mass2700.60
IUPAC Name5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine
SMILESCCC(C)c1nc(-c2cnc(C)c(C(F)(F)F)c2)cn1C12CC(N3CCOCC3)(C1)C2.CCC(C)c1nc(-c2cnc(N)c(C)c2)cn1C12CC(N3CCOCC3)(C1)C2.CCC(C)c1nc(-c2cnc(N)c(C)c2)cn1C12CC(N3CCOCC3)(C1)C2.CCc1nc(-c2cnc(N)c(C)c2)cn1C12CC(N3CCOCC3)(C1)C2.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC(C)C)n2)cnc1N.Cc1ncc(-c2cn(C34CC(C3)C4)c(C(C)C)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC(C)C)n2)cc1C(F)(F)F
InChIInChI=1S/2C23H29F3N4O.3C22H31N5O.C20H27N5O.C18H20F3N3/c1-15(2)8-20-28-19(17-9-18(23(24,25)26)16(3)27-10-17)11-30(20)22-12-21(13-22,14-22)29-4-6-31-7-5-29;1-4-15(2)20-28-19(17-9-18(23(24,25)26)16(3)27-10-17)11-30(20)22-12-21(13-22,14-22)29-5-7-31-8-6-29;1-15(2)8-19-25-18(17-9-16(3)20(23)24-10-17)11-27(19)22-12-21(13-22,14-22)26-4-6-28-7-5-26;2*1-4-15(2)20-25-18(17-9-16(3)19(23)24-10-17)11-27(20)22-12-21(13-22,14-22)26-5-7-28-8-6-26;1-3-17-23-16(15-8-14(2)18(21)22-9-15)10-25(17)20-11-19(12-20,13-20)24-4-6-26-7-5-24;1-10(2)16-23-15(9-24(16)17-5-12(6-17)7-17)13-4-14(18(19,20)21)11(3)22-8-13/h2*9-11,15H,4-8,12-14H2,1-3H3;3*9-11,15H,4-8,12-14H2,1-3H3,(H2,23,24);8-10H,3-7,11-13H2,1-2H3,(H2,21,22);4,8-10,12H,5-7H2,1-3H3
InChIKeySBPDEPNELOYPOK-UHFFFAOYSA-N
XLogP26.07
TPSA393.87 Ų
H-Bond Donors4
H-Bond Acceptors37
Rotatable Bonds32
Heavy Atoms196
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002702.43
LogP ≤ 526.07
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1037

Analyze 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine?
The IUPAC name of 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine (CID 160789018) is 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine.
What is the SMILES notation for 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine?
The canonical SMILES for 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine is CCC(C)c1nc(-c2cnc(C)c(C(F)(F)F)c2)cn1C12CC(N3CCOCC3)(C1)C2.CCC(C)c1nc(-c2cnc(N)c(C)c2)cn1C12CC(N3CCOCC3)(C1)C2.CCC(C)c1nc(-c2cnc(N)c(C)c2)cn1C12CC(N3CCOCC3)(C1)C2.CCc1nc(-c2cnc(N)c(C)c2)cn1C12CC(N3CCOCC3)(C1)C2.Cc1cc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC(C)C)n2)cnc1N.Cc1ncc(-c2cn(C34CC(C3)C4)c(C(C)C)n2)cc1C(F)(F)F.Cc1ncc(-c2cn(C34CC(N5CCOCC5)(C3)C4)c(CC(C)C)n2)cc1C(F)(F)F.
What is the InChIKey of 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine?
The InChIKey is SBPDEPNELOYPOK-UHFFFAOYSA-N. The full InChI is InChI=1S/2C23H29F3N4O.3C22H31N5O.C20H27N5O.C18H20F3N3/c1-15(2)8-20-28-19(17-9-18(23(24,25)26)16(3)27-10-17)11-30(20)22-12-21(13-22,14-22)29-4-6-31-7-5-29;1-4-15(2)20-28-19(17-9-18(23(24,25)26)16(3)27-10-17)11-30(20)22-12-21(13-22,14-22)29-5-7-31-8-6-29;1-15(2)8-19-25-18(17-9-16(3)20(23)24-10-17)11-27(19)22-12-21(13-22,14-22)26-4-6-28-7-5-26;2*1-4-15(2)20-25-18(17-9-16(3)19(23)24-10-17)11-27(20)22-12-21(13-22,14-22)26-5-7-28-8-6-26;1-3-17-23-16(15-8-14(2)18(21)22-9-15)10-25(17)20-11-19(12-20,13-20)24-4-6-26-7-5-24;1-10(2)16-23-15(9-24(16)17-5-12(6-17)7-17)13-4-14(18(19,20)21)11(3)22-8-13/h2*9-11,15H,4-8,12-14H2,1-3H3;3*9-11,15H,4-8,12-14H2,1-3H3,(H2,23,24);8-10H,3-7,11-13H2,1-2H3,(H2,21,22);4,8-10,12H,5-7H2,1-3H3.
What are the key properties of 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine?
5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine has a molecular weight of 2702.43 g/mol, XLogP of 26.07, 32 rotatable bonds, 4 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[1-(1-bicyclo[1.1.1]pentanyl)-2-propan-2-ylimidazol-4-yl]-2-methyl-3-(trifluoromethyl)pyridine;4-[3-[2-butan-2-yl-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine;bis(5-[2-butan-2-yl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine);5-[2-ethyl-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]-3-methylpyridin-2-amine;3-methyl-5-[2-(2-methylpropyl)-1-(3-morpholin-4-yl-1-bicyclo[1.1.1]pentanyl)imidazol-4-yl]pyridin-2-amine;4-[3-[2-(2-methylpropyl)-4-[6-methyl-5-(trifluoromethyl)-3-pyridinyl]imidazol-1-yl]-1-bicyclo[1.1.1]pentanyl]morpholine is sourced from PubChem (CID 160789018), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).